DOI: 10.1002/ccr3.8791 ISSN: 2050-0904
Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report
Harman Chopra, Tim Furnish, Monica Verduzco‐Gutierrez, David S. Jevotovsky, Joel CastellanosKey Clinical Message
Long‐COVID syndrome lacks effective holistic treatment options. We present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who obtained significant symptomatic relief after self‐medicating with psilocybin and MDMA.
Abstract
Long‐COVID, a syndrome persisting after the acute phase of coronavirus disease 2019 (COVID‐19), lacks effective holistic treatment options. We present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who obtained significant symptomatic relief by self‐prescribing psilocybin and MDMA. Future research is needed to assess safety and efficacy.